Tomiyama Yasuyuki, Takenaka Kazuyuki, Kodama Takahiro, Kawanaka Miwa, Sasaki Kyo, Nishina Sohji, Yoshioka Naoko, Hara Yuichi, Hino Keisuke
Department of Hepatology and Pancreatology, Kawasaki Medical School, Japan.
Intern Med. 2013;52(14):1553-9. doi: 10.2169/internalmedicine.52.0010. Epub 2013 Jul 15.
Early diagnosis of hepatocellular carcinoma (HCC) is critical in the management of patients with primary biliary cirrhosis (PBC), since the prognosis of PBC has improved. The aim of this study was to investigate whether HCC development affects the prognosis of PBC and to identify the risk factors for HCC in Japanese patients with PBC.
We compared the survival rates between patients with HCC and those without and analyzed the risk factors for HCC development in 210 patients with PBC who were followed up for a median period of 8.5 years.
HCC developed during follow-up in 11 patients (5.2%) and was diagnosed simultaneously at the time of diagnosis of PBC in five patients (2.4%) who were excluded from the analysis. A Kaplan-Meier analysis showed a significant difference in overall survival between the patients who did and did not develop HCC (p<0.001). A multivariate analysis revealed age (OR: 1.08, 95% confidence interval [CI]: 1.03-1.13, p=0.001), the albumin level (OR: 0.24, 95% CI: 0.10-0.56, p=0.001), the total bilirubin level (OR: 1.60, 95% CI: 1.09-2.36, p=0.017) and HCC development (OR: 2.97, 95% CI: 1.24-7.15, p=0.015) to be significant prognostic factors and identified only an advanced histological stage (Scheuer's classification III or IV, OR: 6.27, 95% CI: 1.80-21.83, p=0.004) to be a risk factor associated with HCC.
HCC development significantly affects the survival of patients with PBC, and an advanced histological stage is the only risk factor associated with HCC development. These results highlight the important role of liver fibrosis in hepatocarcinogenesis in patients with PBC.
随着原发性胆汁性肝硬化(PBC)患者预后的改善,肝细胞癌(HCC)的早期诊断对于PBC患者的管理至关重要。本研究的目的是调查HCC的发生是否会影响PBC的预后,并确定日本PBC患者发生HCC的危险因素。
我们比较了发生HCC的患者与未发生HCC的患者的生存率,并分析了210例PBC患者发生HCC的危险因素,这些患者的中位随访时间为8.5年。
在随访期间,11例患者(5.2%)发生了HCC,另有5例患者(2.4%)在PBC诊断时同时被诊断出HCC,这5例患者被排除在分析之外。Kaplan-Meier分析显示,发生HCC的患者与未发生HCC的患者的总生存率存在显著差异(p<0.001)。多因素分析显示,年龄(比值比[OR]:1.08,95%置信区间[CI]:1.03-1.13,p=0.001)、白蛋白水平(OR:0.24,95%CI:0.10-0.56,p=0.001)、总胆红素水平(OR:1.60,95%CI:1.09-2.36,p=0.017)和HCC的发生(OR:2.97,95%CI:1.24-7.15,p=0.015)是显著的预后因素,并且仅确定晚期组织学分期(Scheuer分类III或IV,OR:6.27,95%CI:1.80-21.83,p=0.004)是与HCC相关的危险因素。
HCC的发生显著影响PBC患者的生存,晚期组织学分期是与HCC发生相关的唯一危险因素。这些结果突出了肝纤维化在PBC患者肝癌发生中的重要作用。